DK0424351T3 - Anvendelse af modificeret heparin-cofaktor II - Google Patents

Anvendelse af modificeret heparin-cofaktor II

Info

Publication number
DK0424351T3
DK0424351T3 DK90870188.1T DK90870188T DK0424351T3 DK 0424351 T3 DK0424351 T3 DK 0424351T3 DK 90870188 T DK90870188 T DK 90870188T DK 0424351 T3 DK0424351 T3 DK 0424351T3
Authority
DK
Denmark
Prior art keywords
heparin cofactor
modified heparin
hcii
modified
cofactor
Prior art date
Application number
DK90870188.1T
Other languages
Danish (da)
English (en)
Inventor
Douglas Meyer Tollefsen
Vivianna Maia Derechin
Morey Alan Blinder
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0424351T3 publication Critical patent/DK0424351T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK90870188.1T 1989-10-20 1990-10-15 Anvendelse af modificeret heparin-cofaktor II DK0424351T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/424,440 US5102995A (en) 1989-10-20 1989-10-20 Dna encoding modified heparin cofactor ii

Publications (1)

Publication Number Publication Date
DK0424351T3 true DK0424351T3 (da) 1997-10-13

Family

ID=23682642

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90870188.1T DK0424351T3 (da) 1989-10-20 1990-10-15 Anvendelse af modificeret heparin-cofaktor II

Country Status (9)

Country Link
US (1) US5102995A (fr)
EP (1) EP0424351B1 (fr)
JP (1) JPH03139280A (fr)
AT (1) ATE154388T1 (fr)
CA (1) CA2028082A1 (fr)
DE (1) DE69030909T2 (fr)
DK (1) DK0424351T3 (fr)
ES (1) ES2104598T3 (fr)
GR (1) GR3024588T3 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871956A (en) * 1984-12-06 1999-02-16 Amgen Inc. Recombinant methods for production of serine inhibitors and DNA sequences useful for same
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
US6132990A (en) * 1984-12-06 2000-10-17 Amgen Boulder Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
GB9024685D0 (en) * 1990-11-13 1991-01-02 Raleigh Industries Ltd Cycle seat pillar mounting
JP3479539B2 (ja) * 1992-04-10 2003-12-15 エーザイ株式会社 ヒトアンチトロンビンiii変異体
US6303691B1 (en) 1992-07-31 2001-10-16 Exxon Mobil Chemical Patents Inc. Impact modification of polyamides
US6869925B1 (en) * 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
JPH09176040A (ja) * 1995-12-27 1997-07-08 Green Cross Corp:The ヘパリンコファクターiiの医薬用途
AU2878199A (en) * 1998-02-27 1999-09-15 University Of North Carolina At Chapel Hill, The Mutant heparin cofactor ii
AU2746399A (en) * 1998-03-09 1999-09-27 Welfide Corporation Heparin cofactor ii-containing compositions and method for stabilizing the same
GB0916578D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
GB2500184A (en) * 2012-03-12 2013-09-18 Ximmune Ab Polypeptide derived from helix A of heparin cofactor II
US20180078916A1 (en) * 2015-03-18 2018-03-22 Carnegie Mellon University Lignin-based surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3521226A1 (de) * 1985-02-08 1986-08-14 Hoechst Ag, 6230 Frankfurt Gene fuer biologisch aktive proteine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide

Also Published As

Publication number Publication date
EP0424351A2 (fr) 1991-04-24
DE69030909D1 (de) 1997-07-17
GR3024588T3 (en) 1997-12-31
EP0424351A3 (en) 1991-10-09
EP0424351B1 (fr) 1997-06-11
US5102995A (en) 1992-04-07
ATE154388T1 (de) 1997-06-15
ES2104598T3 (es) 1997-10-16
CA2028082A1 (fr) 1991-04-21
JPH03139280A (ja) 1991-06-13
DE69030909T2 (de) 1998-01-29

Similar Documents

Publication Publication Date Title
DK0424351T3 (da) Anvendelse af modificeret heparin-cofaktor II
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
BR1100970A (pt) Composto, e, composição farmacêutica útil no tratamento de doença cardiovascular, tal como hipertensão e deficiência cardìaca congestiva
ES2078291T3 (es) Nuevos derivados de acido a-nor-esteroide-3-carboxilico.
DE3751742D1 (de) 4,5,6-Substituierte 2-Pyrimidinamine
DE68925155D1 (de) Verwendung von Halogenkohlenwasserstofflösungsmittel als Reinigungsmittel
DK399588A (da) Pentasaccharider
HUT77431A (hu) Fonálféregből kivont szerinproteáz-inhibitorok és véralvadásgátló proteinek
OA09470A (en) 2-substituted-4-substituted-1,3-dioxolanes, synthesis and use thereof.
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
DE68918681D1 (de) Glycosidasehemmer.
DK270789D0 (da) Hirudin-derivater, deres fremstilling og anvendelse
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
UA26435A (uk) Каталізатор полімеризації альфа-олефіhів, спосіб одержаhhя поліолефіhів з його використаhhям
ATE194331T1 (de) Pyridinderivate als fungizide
DE69122376D1 (de) Hochreine Thrombinzubereitung
ES2060392T3 (es) Nueva region promotora.
ATE238791T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
MY104566A (en) Beta-lactam derivatives.
DK0618234T3 (da) Fremgangsmåde til fremstilling af semisyntetiske glycosaminoglycaner med heparin- eller heparanstruktur som er modificeret i 2-stillingen af alfa-L-iduron-2-O-sulfatsyren
MX9204642A (es) 1,4-dihidropiridinas con actividad paf-antagonista
DE59406741D1 (de) Herzstückspitze
DE69023964D1 (de) Verwendung von Isoxazolin-3-one-Derivaten als Antidepressiva.
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
NO903488D0 (no) Ny forbindelse.